πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9440990

1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative di

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9434758

Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9435804

Detection, prevention, and treatment of anthrax and other infectious diseases

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9433624

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421240

Compstatin analogs for treatment of neuropathic pain

Apellis Pharmaceuticals, Inc. Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422556

RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesi

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421185

Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tr

The Regents of the University of California Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9410154

HBV treatment

Benitec Biopharma Limited Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9408839

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9402881

Tissue regeneration and wound treatment methods with platelet derived compositions

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9403911

Compositions and methods for detection and treatment of cancer

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9402935

Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and an

Lutonix, Inc. Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9402820

Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for th

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9399034

Methods of sedation during critical care treatment

OVID THERAPEUTICS INC. Β· Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9399648

Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9393271

GHRH agonists for islet cell transplantation and function and the treatment of diabetes

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394359

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

China Synthetic Rubber Corporation Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387224

Treatment of specific cardiovascular conditions with nitrite

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388163

Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9375475

Combination immunotherapy for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9370527

Amelioration of intestinal fibrosis and treatment of Crohn's disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9364448

Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9364505

Therapeutic composition for treatment of glioblastoma

Regents of the University of Minnesota Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9364501

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted